Source link : https://www.newshealth.biz/health-news/sglt2-inhibitors-protective-against-retinopathy-in-t2d/
TOPLINE: Sodium-glucose cotransporter 2 (SGLT2) inhibitors are associated with a lower risk for sight-threatening retinopathy than other second-line glucose-lowering medications in patients with type 2 diabetes (T2D). METHODOLOGY: Researchers conducted a nationwide cohort study including 3,544,383 patients with newly diagnosed T2D. During the 5-year study period, 159,965 patients were treated with SGLT2 inhibitors, 304,383 received […]
Author : News Health
Publish date : 2024-01-23 09:21:21
Copyright for syndicated content belongs to the linked Source.